"Designing Growth Strategies is in our DNA"
A surgical microscope, also defined as an operating microscope, is specifically designed to be used in a surgical setting, especially for microsurgery. It delivers clear and sharply focused images, and the modular system gives the surgeon optimum maneuverability through 3D visualization and magnification of deep surgical fields through small approaches. Technological advancements in surgical microscopes have significantly improved vision, stability, and sizing, positioning, and recording capabilities and helped integrate image-guided microscope systems for better outcomes.
The population is aging rapidly across the globe, owing to increasing life expectancy and reduced birth rates. For instance, according to the United Nations data on World Population Prospects for 2020, the number of people over 65 may increase from 9.3% in 2020 to more than 16.0% of the total world population by 2050. Hence, the prevalence of age-associated chronic diseases and subsequent surgical interventions have also increased, which, in turn, has resulted in the market's expansion. However, factors like the high cost of advanced operating microscopes and the lack of required medical infrastructure in developing and underdeveloped regions are likely to thwart the growth of the surgical microscopes market to an extent.
During the COVID-19 pandemic, a decrease in surgical procedures was recorded in all the countries, as the respective government recommended that surgery centers and hospitals cancel or postpone elective procedures. With that decline in surgical procedures worldwide, the growing demand for surgical microscopes witnessed a downfall for the time being. According to statistics published by World Economic Forum, around 28.4 million elective surgeries worldwide were canceled or postponed in May 2020.
However, the resumption of elective procedures and business operations of companies within the given guidelines worldwide is expected to propel market growth in the coming years. Rising demand for minimally invasive procedures to reduce hospital expenditure and post-surgical stay, along with rescheduling the pending procedures during the pandemic, is anticipated to drive the market for new surgical microscopes worldwide. Moreover, increasing post-pandemic collaborations among the leading industry players will positively impact the market. For instance, in December 2021, Leica Microsystems and SurgicalOne expanded their partnership to distribute surgical microscopes in Maryland, Virginia, and Washington D.C.
The report will cover the following key insights:
Based on type, the global surgical microscope market has been segmented into casters microscopes, wall mounted microscopes, tabletop microscopes, and ceiling mounted microscopes. On casters segment by type is expected to account for a remarkable share due to the better portability & flexibility and low maintenance of these tools. Moreover, the same segment is expected to account for significant growth over the forecast period due to the high use of casters microscope in various surgical fields, including dental, cosmetics procedures, and ENT. Such microscopes are used in examination or operating rooms with limited space.
Based on application, the market is segregated into dentistry, ENT surgery, neurosurgery, oncology, plastic & reconstructive surgeries, ophthalmology, and other surgeries. The ophthalmology segment is anticipated to account for a significant market share due to increased demand for devices to fulfill the surgical requirements, a rising patient pool, and an increased volume of cataract surgeries. In addition, the same segment is expected to hold a significant share during the forecast period owing to factors like increasing R&D activities in the pharmaceutical & medical device industry, a rise in demand for use in surgical procedures, and a surge in the adoption of surgical instruments.
Similarly, the neurosurgery and spine surgery segment is anticipated to witness lucrative growth during the forecast period.
Based on end users, the market has been segmented into hospitals, clinics, and others. The hospital's segment is expected to account for a significant share of the surgical microscopes market. Key factors include a higher number of patient admissions & surgeries performed in hospitals and the implementation less-invasive surgical instruments during MIS procedures. Additionally, an exponential increase in the utilization of advanced and innovative surgical microscopes are crucial factor likely to propel the segment. For instance, Hartford HealthCare St. Vincent’s Medical Center in Bridgeport is the first hospital in New England to use Synaptive’s Modus V3D exoscope technology for brain and spine surgeries. Modus V is a robotic digital microscope that uses artificial intelligence to combine advanced engineering with the latest breakthroughs in optics, video processing, and robotic automation.
To gain extensive insights into the market, Request for Customization
North America is anticipated to dominate the surgical microscope market. The dominant share is attributed to the availability of highly advanced equipment, skilled neurosurgeons, and cosmetic surgeons. Similarly, the increasing number of surgical facilities, the supportive reimbursement framework for medical treatments, and the preference for outpatient settings will boost the regional market share. Similarly, regional companies are launching innovative products, which is also expected to augment the market growth in North America. For instance, in September 2020, True Digital Surgery (TDS) and Aesculap, Inc. launched Aesculap Aeos Robotic Digital Microscope in the United States.
The report will include the profiles of key players such as Novartis AG, Karl Kaps GmbH & Co. Kg, Hagg-Streit Surgical GMBH (MÖLLER-WEDEL GMBH), Takagi Seiko Co. Ltd., Leica Microsystems (Danaher Corporation), Carl Zeiss Meditec AG (Carl Zeiss AG), Alcon, Inc., Olympus Corporation, Seiler Instrument, Inc., Arri Medical (Arri Group) and others.
By Type | By Application | By End User | By Geography |
Mounted |
|
|
|
US +1 833 909 2966 ( Toll Free )